Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07010835
Recruiting
Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus
Phase 1/2 · China · 1 site
Registry update: 5 Feb 2026
NCT07928167
Recruiting
Lenvatinib And Stereotactic radiothErapy With pembRolizumab in Metastatic Kidney Cancer Patients
Phase 2 · Russia · 8 sites
Registry update: 10 Nov 2026
NCT07555210
Recruiting
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
Not applicable · United States · 1 site
Registry update: 6 May 2026
NCT07142954
Recruiting
Epidemiology and Biomarker Study in Alzheimer's Disease
Phase 3 · Japan, United States · 4 sites
Registry update: 7 Jul 2026
NCT07087587
Recruiting
Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):
Not applicable · United States · 2 sites
Registry update: 13 Apr 2026
NCT07546123
Recruiting
Ovarian Tissue Cryopreservation Combined With Oocyte Cryopreservation Versus Oocyte Cryopreservation Alone
Not applicable · Italy · 1 site
Registry update: 22 Apr 2026
NCT07383246
Recruiting
CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
Phase 3 · China · 1 site
Registry update: 3 Feb 2026
NCT01311323
Recruiting
Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease
Not applicable · Poland · 9 sites
Registry update: 8 Jul 2026
NCT07081724
Recruiting
"Opt-In" Early Intervention Program for Children Waiting to Receive an Autism Diagnosis
Not applicable · United States · 1 site
Registry update: 28 Jan 2026
NCT07132541
Recruiting
Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)
Phase 1 · Egypt · 1 site
Registry update: 11 Sept 2026
NCT06968637
Recruiting
Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply Side
Not applicable · Bangladesh · 2 sites
Registry update: 22 Oct 2026
NCT07114419
Recruiting
The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE）
Phase 2 · Australia · 5 sites
Registry update: 2 Dec 2025
NCT06414681
Recruiting
Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined
Early phase 1 · United States · 1 site
Registry update: 6 May 2026
NCT07077486
Recruiting
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
Phase 4 · China · 1 site
Registry update: 27 Jan 2026
NCT07171151
Recruiting
Detection of Disease Marker Factors in Cyst Fluid
Not applicable · 1 site
Registry update: 12 Sept 2025
NCT06995573
Recruiting
A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
Phase 1/2 · Austria, Czechia, Germany, Italy · 22 sites
Registry update: 17 Apr 2026
NCT07616700
Recruiting
A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
Phase 2 · China · 1 site
Registry update: 1 Jun 2026
Conflicting statuses (not updated in the registry for 5 months)
NCT06859008
Recruiting
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Phase 1 · United States · 1 site
Registry update: 20 Apr 2026
NCT07141264
Recruiting
Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
Phase 2 · China · 1 site
Registry update: 30 Dec 2025
NCT07594964
Recruiting
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
Phase 1 · China · 2 sites
Registry update: 19 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.